David Fleischer, MD: Benefits of Immunotherapy Product, Hopes for Future of Treatment
In this interview segment, Fleischer further described some of the key points about the peanut immunotherapy patch, DBV712, and the product’s phase 3 VITESSE trial.
Source: hcplive.com